Protarga's new paclitaxel conjugate has favorable PK and toxicity profiles in early clinical studies May 26, 2000
Survival benefit seen in patients with brain tumors or metastases on RSR-13 plus cranial RT May 26, 2000
ASCO news: polymeric CPT derivative assessed in phase I for toxicity and pharmacokinetics May 25, 2000